Statistical Issues in Interpretation of Anti-Estrogen Trials in Early Breast Cancer and a view at Ongoing Prevention Trials

Upon completion of the program, participants will be better able to:

- Recognize the key statistical issues in adjuvant anti-estrogen trials

- Be aware of recent updates in adjuvant anti-estrogen trials

- Be able to optimize adjuvant anti-estrogen strategies from a statistical perspective

- Recognize ongoing trials in chemoprevention

The program is available on the OncologyEducation.ca eLearning Portal.

Click here to access the OncologyEducation eLearning Portal

This program was made possible through an unrestricted educational grant from Astra Zeneca. 

---

---

 

posted Sept 2 2010

Personalizing the Management of Non Small Cell Lung Cancer: A New Era

The online version of this Continuing Medical Education program on Non Small Cell Lung Cancer Cancer is presented by Dr. Sunil Verma, MD, MSED, FRCPC.  Upon completion of the program, participants will be better able to:

- Utilize the evidence from recent clinical trials to guide their therapeutic strategy for patients with NSCLC

- Review future clinical trials designed to help personalize the treatment of NSCLC

- Individualize the treatment of NSCLC patients by considering tumour-related, molecular and clinical factors in the selection of therapy.

 This program contains 3 modules:

- Module 1 - Adjuvant Chemotherapy for Early Stage Non Small Cell Lung Cancer

- Module 2 - First Line and Maintenance Therapy for Advanced Non Small Cell Lung Cancer

- Module 3 - Second Line Treatment for Advanced  Non Small Cell Lung Cancer

The program was the first available CME on the newly launched OncologyEducation.ca eLearning Portal, which will offer oncology-specific CMEs on a variety of topics.

This program was made possible through an unrestricted educational grant from Eli Lilly.

---

---

 

posted Aug 16 2010

Program 1- Meeting the challenge: Evolution of the Management of CLL

This educational program entitled "Meeting the challenge: Evolution of the Management of CLL" prepared and presented by Dr. C.-M. Wendtner (Clinic I of Internal Medicine, University of Cologne, Germany) in a taping session on May 10th, 2010, focuses on the challenges of treating chronic lymphocytic leukemia (CLL) in the elderly. The presentation reviews the results of phase III CLL-8 trial in patients with CLL treated with rituximab plus fludarabine and cyclophosphamide (RFC) vs. FC alone, examines first-line treatment options in both fit and frail (unfit) patients with CLL, and identifies treatment options based on disease stage.

 

Program 2 - PRIMA

This program is a videotaping of a presentation by Dr Gilles Salles in June of 2010 on the PRIMA Study. The program discusses the results of the PRIMA trial (Primary Rituximab and Maintenance).

Click here to launch the programs in a new browser window 

These programs were developed by RxMedia Healthcare and supported through an unrestricted educational grant from Hoffmann-la Roche.

---

---

 

posted Oct 27 2009

ONTarget Resource Guide - Common Side Effects of Targeted Therapy

A downloadable CME program for community-based oncology pharmacists.  This program is endorsed by the Groupe d'étude en oncologie du Québec (GEOQ) and the Canadian Association of Pharmacy in Oncology (CAPhO).

---

---

 Past Live Events:

Best of ASCO Breast 2007- Great Canadian Adjuvant Debate
Monday June 25, 2007
Westin Prince Hotel- 900 York Mills Rd.
Toronto, ON

To View Video